Non-pegylated liposomal doxorubicin (Myocet)

General information

Class/mechanism: A formulation of the citrate salt of the antineoplastic anthracycline antibiotic doxorubicin, encapsulated within liposomes, with antitumor activity.

Diseases for which it is used

• Breast cancer

History of changes in EMA indication

• 4/12/2000: Myocet liposomal, in combination with cyclophosphamide, is indicated for the first-line treatment of metastatic breast cancer in adult women.

Also known as

• Generic names: liposome-encapsulated doxorubicin citrate, NPLD
• Brand name: Myocet